STEAP4
Basic information
Region (hg38): 7:88270892-88306894
Previous symbols: [ "TNFAIP9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (33 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STEAP4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024636.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 31 | 3 | 2 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STEAP4 | protein_coding | protein_coding | ENST00000380079 | 4 | 30463 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.20e-7 | 0.809 | 124512 | 2 | 273 | 124787 | 0.00110 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.843 | 208 | 245 | 0.848 | 0.0000123 | 2948 |
Missense in Polyphen | 64 | 84.686 | 0.75573 | 1022 | ||
Synonymous | 0.266 | 86 | 89.2 | 0.964 | 0.00000431 | 948 |
Loss of Function | 1.45 | 14 | 21.2 | 0.659 | 0.00000145 | 221 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0135 | 0.0133 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000556 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000284 | 0.000282 |
Middle Eastern | 0.0000557 | 0.0000556 |
South Asian | 0.000430 | 0.000425 |
Other | 0.000664 | 0.000660 |
dbNSFP
Source:
- Function
- FUNCTION: Metalloreductase that has the ability to reduce both Fe(3+) to Fe(2+) and Cu(2+) to Cu(1+) (By similarity). Uses NADP(+) as acceptor (By similarity). Plays a role in systemic metabolic homeostasis, integrating inflammatory and metabolic responses (By similarity). Associated with obesity and insulin- resistance (PubMed:18430367, PubMed:18381574). Involved in inflammatory arthritis, through the regulation of inflammatory cytokines (PubMed:19660107). Inhibits anchorage-independent cell proliferation (PubMed:19787193). {ECO:0000250, ECO:0000269|PubMed:18381574, ECO:0000269|PubMed:18430367, ECO:0000269|PubMed:19660107, ECO:0000269|PubMed:19787193}.;
- Pathway
- Vitamin D Receptor Pathway;Copper homeostasis
(Consensus)
Recessive Scores
- pRec
- 0.0817
Intolerance Scores
- loftool
- 0.524
- rvis_EVS
- 0.82
- rvis_percentile_EVS
- 87.95
Haploinsufficiency Scores
- pHI
- 0.102
- hipred
- N
- hipred_score
- 0.167
- ghis
- 0.422
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.375
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Steap4
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- copper ion import;fat cell differentiation;iron ion homeostasis;oxidation-reduction process;iron ion import across cell outer membrane
- Cellular component
- Golgi membrane;endosome;Golgi apparatus;plasma membrane;integral component of membrane;early endosome membrane;extracellular exosome
- Molecular function
- cupric reductase activity;metal ion binding;ferric-chelate reductase (NADPH) activity